Abstract
Purpose
In this study, we aimed to evaluate and compare the visual acuity, macular volume, central macular thickness, change in number of intravitreal ranibizumab injections with micropulse laser applications after loading dose of anti-VEGF to DME patients.
Study Design
Retrospective study.
Methods
This study was carried out on 97 patients (45 ranibizumab and 52 micropulse grid laser+ranibizumab) with diabetic macular edema patients who were followed in the Retina Unit. At the control visit after three loading ranibizumab injections administered once a month, micropulse grid laser was applied to one group and ranibizumab injection was continued PRN to both groups for an average of 9.27 ± 2.42 months and central macular thickness, macular volume and visual acuity were recorded.
Results
There was no significant difference between the groups in terms of gender, smoking and systemic diseases, initial central macular thickness, macular volume and visual acuity measurements (p > 0.05). Central macular thickness, macular volume and visual acuity values measured at the last follow-up of the patients were not significantly different between the groups (p > 0.05). The mean post-treatment injection requirement was 4.19 ± 1.01 for the ranibizumab with micropulse laser combination group and 5.53 ± 1.14 for the ranibizumab group (p < 0.001).
Conclusion
Micropulse laser treatment after initial loading doses reduces the need for anti-VEGF injections. There is no deleterious effect on visual acuity and retinal imagings. Therefore, while combination therapy provides an effective treatment, it can also reduce the risk of complications of intravitreal anti-VEGF injections. Studies with the participation of more patients may help in the selection of treatment methods by comparing micropulse laser combined with different injection protocols.
Similar content being viewed by others
References
Bhagat N, Grigorian RA, Tutela A et al (2009) Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 54:1–32. https://doi.org/10.1016/j.survophthal.2008.10.001
ETDRSr. (1985) Photocoagulation for diabetic macular edema. early treatment diabetic retinopathy study report number 1. early treatment diabetic retinopathy study research group. Arch Ophthalmol 103: 1796–806. https://doi.org/10.1001/archopht.1985.01050120030015
Fong DS, Strauber SF, Aiello LP et al (2007) Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 125:469–480. https://doi.org/10.1001/archopht.125.4.469
Massin P, Massin P, Bandello F, Garweg JG et al (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double masked, multicenter phase II study. Diabetes Care 33(11):2399–2405. https://doi.org/10.2337/dc10-0493
Elman MJ, Aiello LP, Beck RW et al (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064–77.e35. https://doi.org/10.1016/j.ophtha.2010.02.031
Elman MJ, Bressler NM, Qin H et al (2011) Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 118:609–614. https://doi.org/10.1016/j.ophtha.2010.12.033
Solaiman KA, Diab MM, Dabour SA (2013) Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema. Retina 33:1623–1629. https://doi.org/10.1097/IAE.0b013e318285c99d
Schatz H, Madeira D, McDonald HR et al (1991) Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 109:1549–1551. https://doi.org/10.1001/archopht.1991.01080110085041
Lewis H, Schachat AP, Haimann MH, Haller JA, Quinlan P, Von Fricken MA, Fine SL, Murphy RP (1990) Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 97(4):503–511. https://doi.org/10.1016/S0161-6420(90)32574-5
Guyer DR, D’Amico DJ, Smith CW (1992) Subretinal fibrosis after laser photocoagulation for diabetic macular edema. Am J Ophthalmol 113:652–656. https://doi.org/10.1016/s0002-9394(14)74789-0
Roider J, Hillenkamp F, Flotte T et al (1993) Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci U S A 90:8643–8647. https://doi.org/10.1073/pnas.90.18.8643
De Maio A (1999) Heat shock proteins: facts, thoughts, and dreams. Shock 11:1–12. https://doi.org/10.1097/00024382-199901000-00001
Gawęcki M (2019) Micropulse laser treatment of retinal diseases. J Clin Med 8(2):242. https://doi.org/10.3390/jcm8020242
Scholz P, Altay L, Fauser S (2017) A review of subthreshold micropulse laser for treatment of macular disorders. Adv Ther 34:1528–1555. https://doi.org/10.1007/s12325-017-0559-y
Kanar HS, Arsan A, Altun A et al (2020) Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? a randomized clinical trial. Indian J Ophthalmol 68(1):145–151. https://doi.org/10.4103/ijo.IJO_350_19
Mansouri A, Sampat KM, Malik KJ et al (2014) Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness. Eye 28:1418–1424. https://doi.org/10.1038/eye.2014.264
Khattab AM, Hagras SM, AbdElhamid A et al (2019) Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 257:1373–1380. https://doi.org/10.1007/s00417-019-04355-6
Wu Y, Ai P, Ai Z et al (2018) Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: a Bayesian network meta-analysis. Biomed Pharmacother 97:293–299. https://doi.org/10.1016/j.biopha.2017.10.078
Moore SM, Chao DL (2018) Application of subthreshold laser therapy in retinal diseases: a review. Expert Rev Ophthalmol 13:311–320. https://doi.org/10.1080/17469899.2018.1555035
Moisseiev E, Abbassi S, Thinda S et al (2018) Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema. Eur J Ophthalmol 28:68–73. https://doi.org/10.5301/ejo.5001000
Citirik M (2019) The impact of central foveal thickness on the efficacy of subthreshold micropulse yellow laser photocoagulation in diabetic macular edema. Lasers Med Sci 34:907–912. https://doi.org/10.1007/s10103-018-2672-9
Funding
The authors received no financial support for the research, authorship and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bıçak, F., Kayıkçıoğlu, Ö.R., Altınışık, M. et al. Efficacy of subthreshold micropulse laser combined with ranibizumab in the treatment of diabetic macular edema. Int Ophthalmol 42, 3829–3836 (2022). https://doi.org/10.1007/s10792-022-02403-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02403-5